VistaGen Therapeutics, Inc. (NASDAQ ... We encourage you to review the release and our 10-Q, which can be found in the Investors section of our website. We will make forward-looking statements ...

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, marked the sixth anniversary since its ...

Dominic Walsh, a business reporter who previously covered the leisure and drinks industry for The Times from 1997 to 2024, stated in post to X: ...

TG Therapeutics (NASDAQ:TGTX – Free Report) had its target price increased by HC Wainwright from $49.00 to $55.00 in a report ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Friday, TG Therapeutics Inc common stock (TGTX) stock saw a modest uptick, ending the day at $28.81 which represents a slight increase of $0.91 or 3.26% from the prior close of $27.9. The stock ...

Crypto enthusiasts and investors worldwide are invited to participate in the ongoing pre-sale of the highly anticipated ...

US biotech TG Therapeutics has begun a rolling filing with the FDA for its combination therapy for chronic lymphocytic leukaemia, in a challenge to Roche. The New York-based firm has requested ...

Fireside Chat and 1x1 Meetings Interested parties can register for and access the live webcasts for these conferences by visiting the “Events” section of the Rani Therapeutics website.